Literature DB >> 2957720

The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.

A Weizman, I Gil-Ad, D Grupper, S Tyano, Z Laron.   

Abstract

The effects of single and repeated electroconvulsive treatment (ECT) on beta-endorphin (beta-EP), cortisol, growth hormone (GH) and prolactin (Prl) plasma levels were investigated in nine depressed patients. Blood samples were monitored a day before ECT, the day of the first and sixth ECT (0, 30, 60 and 90 min after seizures), the day afterwards and 4 weeks after termination of the ECT course. A significant elevation of beta-EP levels was achieved immediately with and 24 h after the first and the sixth ECT. A transient increase in basal beta-EP was observed 1 day following the sixth ECT in comparison with pre-treatment level. Peak and 30 min levels of cortisol were increased compared with baseline by the first ECT. The former (peak) but not the latter (30 min) were increased also at the sixth treatment. GH levels were decreased the day after the first ECT in comparison with the pre-treatment levels and immediately following each ECT in comparison with baseline. A trend toward elevation of Prl was observed immediately after the first and sixth ECT, although the rise did not reach significant levels. ECT administration stimulated beta-EP and cortisol secretion and suppressed human GH release, possibly by activation of endorphinergic and/or serotonergic systems. These mechanisms might be involved in the beneficial effect of ECT in depression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957720     DOI: 10.1007/bf02439598

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Measurement of beta-endorphin-like immunoreactivity in CSF and plasma of neuropsychiatric patients.

Authors:  H M Emrich; V Höllt; W Kissling; M Fischler; H Heinemann; D von Zerssen; A Herz
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

2.  The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.

Authors:  A P Hansen
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

3.  Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome.

Authors:  J F Deakin; I N Ferrier; T J Crow; E C Johnstone; P Lawler
Journal:  Br J Psychiatry       Date:  1983-12       Impact factor: 9.319

4.  The effect of electroconvulsive therapy on plasma beta-endorphin.

Authors:  J Misiaszek; R C Cork; S R Hameroff; J Finley; J L Weiss
Journal:  Biol Psychiatry       Date:  1984-03       Impact factor: 13.382

5.  Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy.

Authors:  L J Whalley; R Rosie; H Dick; G Levy; A G Watts; W J Sheward; J E Christie; G Fink
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

6.  Factors influencing prolactin release induced by electroconvulsive therapy.

Authors:  J Balldin
Journal:  Acta Psychiatr Scand       Date:  1982-05       Impact factor: 6.392

7.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

8.  Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment.

Authors:  J Vetulani; U Lebrecht; A Pilc
Journal:  Eur J Pharmacol       Date:  1981-11-19       Impact factor: 4.432

9.  Neuroendocrine study of the mechanism of action of electroconvulsive therapy.

Authors:  M Arató; G Bagdy
Journal:  Neuropsychobiology       Date:  1982       Impact factor: 2.328

10.  Serotonergic stimulation of adrenocorticotropin secretion in man.

Authors:  D A Lewis; B M Sherman
Journal:  J Clin Endocrinol Metab       Date:  1984-03       Impact factor: 5.958

View more
  10 in total

1.  Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.

Authors:  Chittaranjan Andrade; Shahid Ahmad Shaikh; Lakshmy Narayan; Christine Blasey; Joseph Belanoff
Journal:  J Neural Transm (Vienna)       Date:  2011-09-16       Impact factor: 3.575

Review 2.  Epilepsy, depression, and growth hormone.

Authors:  Tracy Butler; Patrick Harvey; Lila Cardozo; Yuan-Shan Zhu; Adam Mosa; Emily Tanzi; Fahad Pervez
Journal:  Epilepsy Behav       Date:  2019-02-14       Impact factor: 2.937

3.  Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.

Authors:  M Coote; A Wilkins; E S Werstiuk; M Steiner
Journal:  J Psychiatry Neurosci       Date:  1998-05       Impact factor: 6.186

4.  The effect of intrahippocampal injection of kainic acid on corticosterone release in rats.

Authors:  W M Daniels; A Jaffer; A H Engelbrecht; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1990-05       Impact factor: 3.996

5.  Effect of single and repeated electroconvulsive shock on the hypothalamic-pituitary-adrenal axis and plasma catecholamines in rats.

Authors:  A B Thiagarajan; C H Gleiter; I N Mefford; R L Eskay; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Failed and short seizures associated with prior electroconvulsive therapy.

Authors:  K Tomasson; G Winokur; B Pfohl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

7.  Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia.

Authors:  Nandakumar Nagaraja; Chittaranjan Andrade; Suresh Sudha; Nagendra Madan Singh; J Suresh Chandra; B V Venkataraman
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

8.  Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications.

Authors:  L S Brady; A B Lynn; J R Glowa; D Q Le; M Herkenham
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Increased Risk of Pain after Electroconvulsive Therapy among Depressed Patients: a Nationwide Study in Taiwan.

Authors:  Ching-En Lin; Chi-Hsiang Chun; Li-Fen Chen; Wu-Chien Chien
Journal:  Psychiatr Q       Date:  2020-03

Review 10.  Electroconvulsive therapy in the management of chronic pain.

Authors:  Keith G Rasmussen; Teresa A Rummans
Journal:  Curr Pain Headache Rep       Date:  2002-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.